Wird geladen...
Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status
BACKGROUND: Lung cancers with anaplastic lymphoma kinase rearrangements are highly sensitive to anaplastic lymphoma kinase tyrosine kinase inhibition, underscoring the notion that such cancers are addicted to anaplastic lymphoma kinase activity. Several anaplastic lymphoma kinase inhibitors have bee...
Gespeichert in:
| Veröffentlicht in: | BMC Res Notes |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794901/ https://ncbi.nlm.nih.gov/pubmed/26987388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-1983-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|